C25H48N6O10
Neat
592.69
Plazomicin; 1154757-24-0; ACHN-490; plazomicina; plazomicine; LYO9XZ250J; ACHN490; (2S)-4-amino-N-[(1R, 2S, 3S, 4R, 5S)-5-amino-4-[[(2S, 3R)-3-amino-6-[(2-hydroxyethylamino)methyl]-3, 4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R, 3R, 4R, 5R)-3, 5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide; DTXSID001031303; plazomicinum; (2S)-4-amino-N-((1R, 2S, 3S, 4R, 5S)-5-amino-4-(((2S, 3R)-3-amino-6-((2-hydroxyethylamino)methyl)-3, 4-dihydro-2H-pyran-2-yl)oxy)-2-((2R, 3R, 4R, 5R)-3, 5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl)oxy-3-hydroxycyclohexyl)-2-hydroxybutanamide; Zemdri (plazomicin); RefChem:57056; J01GB14; DTXCID901516308; Plazomicin [USAN]; ACHN 490; Plazomicin (USAN); (2S)-4-amino-N-[(1R, 2S, 3S, 4R, 5S)-5-amino-4-{[(2S, 3R)-3-amino-6-{[(2-hydroxyethyl)amino]methyl}-3, 4-dihydro-2H-pyran-2-yl]oxy}-2-{[(2R, 3R, 4R, 5R)-3 and 5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy}-3-hydroxycyclohexyl]-2-hydroxybutanamide; Plazomicin [USAN:INN]
(2S)-4-amino-N-[(1R, 2S, 3S, 4R, 5S)-5-amino-4-[[(2S, 3R)-3-amino-6-[(2-hydroxyethylamino)methyl]-3, 4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R, 3R, 4R, 5R)-3 and 5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide
InChI=1S/C25H48N6O10/c1-25(37)11-38-24(18(35)21(25)29-2)41-20-15(31-22(36)16(33)5-6-26)9-14(28)19(17(20)34)40-23-13(27)4-3-12(39-23)10-30-7-8-32/h3,13-21,23-24,29-30,32-35,37H,4-11,26-28H2,1-2H3,(H,31,36)/t13-,14+,15-,16+,17+,18-,19-,20+,21-,23-,24-,25+/m1/s1